Kidney injury in COVID-19 patients, drug development and their renal complications: Review study
出版年份 2021 全文链接
标题
Kidney injury in COVID-19 patients, drug development and their renal complications: Review study
作者
关键词
SARS-CoV-2, COVID-19, Acute kidney injury, ACE2, Histopathologic damages
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 142, Issue -, Pages 111966
出版商
Elsevier BV
发表日期
2021-07-27
DOI
10.1016/j.biopha.2021.111966
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity
- (2021) Sunil Raghav et al. Frontiers in Microbiology
- Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
- (2021) Amin Gasmi et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis
- (2021) Shi Zhao et al. JOURNAL OF TRAVEL MEDICINE
- Effect of the new SARS-CoV-2 variant B.1.1.7 on children and young people
- (2021) Sarah Brookman et al. Lancet Child & Adolescent Health
- Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
- (2021) Rachana Singh et al. Frontiers in Pharmacology
- Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
- (2021) Mona Sadat Mirtaleb et al. BIOMEDICINE & PHARMACOTHERAPY
- Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021
- (2021) Finlay Campbell et al. Eurosurveillance
- Delta coronavirus variant: scientists brace for impact
- (2021) Ewen Callaway NATURE
- Urinary Levels of SARS-CoV-2 Nucleocapsid Protein Associate With Risk of AKI and COVID-19 Severity: A Single-Center Observational Study
- (2021) Désirée Tampe et al. Frontiers in Medicine
- Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
- (2020) Alexandre Sepriano et al. ANNALS OF THE RHEUMATIC DISEASES
- The Novel Coronavirus Originating in Wuhan, China
- (2020) Alexandra L. Phelan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- COVID-19: combining antiviral and anti-inflammatory treatments
- (2020) Justin Stebbing et al. LANCET INFECTIOUS DISEASES
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- COVID‐19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine
- (2020) Francesco Fontana et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More
- (2020) Abinit Saha et al. ARCHIVES OF MEDICAL RESEARCH
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
- (2020) Tomasz J Guzik et al. CARDIOVASCULAR RESEARCH
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Renin-angiotensin system inhibitors in COVID-19
- (2020) George Thomas CLEVELAND CLINIC JOURNAL OF MEDICINE
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
- (2020) N. Lian et al. CLINICAL MICROBIOLOGY AND INFECTION
- Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019‐nCoV Infection
- (2020) Yin‐Xiao Du et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
- (2020) Shivraj Hariram Nile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Doxycycline, a widely used antibiotic in dermatology with a possible anti‐inflammatory action against IL ‐6 in COVID ‐19 outbreak
- (2020) Claudio Conforti et al. Dermatologic Therapy
- Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients
- (2020) Justin Stebbing et al. EMBO Molecular Medicine
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells
- (2020) Manoocher Soleimani INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary
- (2020) Mohamed A. Hendaus JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Tocilizumab for the treatment of severe coronavirus disease 2019
- (2020) Rand Alattar et al. JOURNAL OF MEDICAL VIROLOGY
- Lopinavir/ritonavir use in Covid-19 infection: is it completely non-beneficial?
- (2020) Adewale Bayode Owa et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Collapsing glomerulopathy in a COVID-19 patient
- (2020) Sébastien Kissling et al. KIDNEY INTERNATIONAL
- Kidney disease is associated with in-hospital death of patients with COVID-19
- (2020) Yichun Cheng et al. KIDNEY INTERNATIONAL
- Acute kidney injury in patients hospitalized with COVID-19
- (2020) Jamie S. Hirsch et al. KIDNEY INTERNATIONAL
- Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China
- (2020) Hua Su et al. KIDNEY INTERNATIONAL
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury
- (2020) Meghan E. Sise et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: rapid review
- (2020) Andrew Dagens et al. BMJ-British Medical Journal
- COVID-19: Knowns, Unknowns, and Questions
- (2020) Stuart Weston et al. mSphere
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Acute Kidney Injury in Coronavirus Disease 2019 Infected Patients: A Meta-Analytic Study
- (2020) Nicola Brienza et al. BLOOD PURIFICATION
- Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID‐19 Infection
- (2020) Melanie R. Nicol et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Role of inflammatory markers in corona virus disease (COVID-19) patients: A review
- (2020) Jyoti Upadhyay et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Acute kidney injury in critically ill patients with COVID-19
- (2020) Paul Gabarre et al. INTENSIVE CARE MEDICINE
- Promising Effects of Tocilizumab in COVID-19: A Non-Controlled, Prospective Clinical Trial
- (2020) Farzaneh Dastan et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
- (2020) Dong Huang et al. JOURNAL OF MEDICAL VIROLOGY
- Kidney Biopsy Findings in Patients with COVID-19
- (2020) Satoru Kudose et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype
- (2020) Huijuan Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Postmortem Kidney Pathology Findings in Patients with COVID-19
- (2020) Dominick Santoriello et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19
- (2020) Sarah C.J. Jorgensen et al. PHARMACOTHERAPY
- Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
- (2020) Hongjing Gu et al. SCIENCE
- COVID-19 and the Kidneys: An Update
- (2020) Claudia Benedetti et al. Frontiers in Medicine
- Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
- (2020) A. Cortegiani et al. Pulmonology
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
- (2020) Mayla Gabriela Silva Borba et al. JAMA Network Open
- Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
- (2020) Jean Claude Alvarez et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir
- (2020) Chengyuan Liang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
- (2020) Tarek Mohamed Abd El-Aziz et al. INFECTION GENETICS AND EVOLUTION
- COVID-19: discovery, diagnostics and drug development
- (2020) Tarik Asselah et al. JOURNAL OF HEPATOLOGY
- Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
- (2020) Chih-Jen Yang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- AKI in Hospitalized Patients with COVID-19
- (2020) Lili Chan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2020) Peter W Horby et al. LANCET
- Azithromycin for severe COVID-19
- (2020) Catherine E Oldenburg et al. LANCET
- COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
- (2020) Nicholas J. White et al. PLOS MEDICINE
- COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management
- (2020) Md. Farhad Hossain et al. Frontiers in Pharmacology
- Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19
- (2020) Sarah M Lofgren et al. Open Forum Infectious Diseases
- Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
- (2020) Marzieh Nojomi et al. BMC INFECTIOUS DISEASES
- Role of favipiravir in the treatment of COVID-19
- (2020) Shashank Joshi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The stimulation of thrombosis by hypoxia
- (2019) Neha Gupta et al. THROMBOSIS RESEARCH
- Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
- (2019) Marc Desforges et al. Viruses-Basel
- Cyclophilin A and CD147 associate with progression of diabetic nephropathy
- (2018) Ping-Fang Chiu et al. FREE RADICAL RESEARCH
- Protective effect of Malva sylvestris L. extract in ischemia-reperfusion induced acute kidney and remote liver injury
- (2017) Houshang Najafi et al. PLoS One
- Tocilizumab (Actemra)
- (2017) Martin Sheppard et al. Human Vaccines & Immunotherapeutics
- The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
- (2016) Eve-Isabelle Pécheur et al. JOURNAL OF VIROLOGY
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
- (2014) Adriaan H. de Wilde et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
- (2014) Jack G. Shi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics, Metabolism, and Excretion of the Antiviral Drug Arbidol in Humans
- (2013) Pan Deng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
- Tocilizumab
- (2009) Vicki Oldfield et al. DRUGS
- Impact of mild hypoxemia on renal function and renal resistive index during mechanical ventilation
- (2009) Michael Darmon et al. INTENSIVE CARE MEDICINE
- Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
- (2008) Y. Boriskin et al. CURRENT MEDICINAL CHEMISTRY
- Role of Interleukin-6 in Bleomycin-Induced Lung Inflammatory Changes in Mice
- (2007) Fumitake Saito et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now